Literature DB >> 34314751

Fear conditioning and extinction in obsessive-compulsive disorder: A systematic review.

Samuel E Cooper1, Joseph E Dunsmoor2.   

Abstract

Laboratory experiments using fear conditioning and extinction protocols help lay the groundwork for designing, testing, and optimizing innovative treatments for anxiety-related disorders. Yet, there is limited basic research on fear conditioning and extinction in obsessive-compulsive disorder (OCD). This is surprising because exposure-based treatments based on associative learning principles are among the most popular and effective treatment options for OCD. Here, we systematically review and critically assess existing aversive conditioning and extinction studies of OCD. Across 12 studies, there was moderate evidence that OCD is associated with abnormal acquisition of conditioned responses that differ from comparison groups. There was relatively stronger evidence of OCD's association with impaired extinction processes. This included multiple studies finding elevated conditioned responses during extinction learning and poorer threat/safety discrimination during recall, although a minority of studies yielded results inconsistent with this conclusion. Overall, the conditioning model holds value for OCD research, but more work is necessary to clarify emerging patterns of results and increase clinical translational utility to the level seen in other anxiety-related disorders. We detail limitations in the literature and suggest next steps, including modeling OCD with more complex conditioning methodology (e.g., semantic/conceptual generalization, avoidance) and improving individual-differences assessment with dimensional techniques.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  acquisition; classical conditioning; clinical translation; disgust-conditioning; exposure therapy; extinction; fear-conditioning; obsessive-compulsive disorder

Mesh:

Year:  2021        PMID: 34314751      PMCID: PMC8429207          DOI: 10.1016/j.neubiorev.2021.07.026

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   9.052


  210 in total

Review 1.  Salience processing and insular cortical function and dysfunction.

Authors:  Lucina Q Uddin
Journal:  Nat Rev Neurosci       Date:  2014-11-19       Impact factor: 34.870

2.  Neural signatures of human fear conditioning: an updated and extended meta-analysis of fMRI studies.

Authors:  M A Fullana; B J Harrison; C Soriano-Mas; B Vervliet; N Cardoner; A Àvila-Parcet; J Radua
Journal:  Mol Psychiatry       Date:  2015-06-30       Impact factor: 15.992

Review 3.  State-of-the-art and future directions for extinction as a translational model for fear and anxiety.

Authors:  Michelle G Craske; Dirk Hermans; Bram Vervliet
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-19       Impact factor: 6.237

Review 4.  Understanding obsessive-compulsive disorder: focus on decision making.

Authors:  Paolo Cavedini; Alessandra Gorini; Laura Bellodi
Journal:  Neuropsychol Rev       Date:  2006-03       Impact factor: 7.444

5.  Neural signatures of conditioning, extinction learning, and extinction recall in posttraumatic stress disorder: a meta-analysis of functional magnetic resonance imaging studies.

Authors:  Benjamin Suarez-Jimenez; Anton Albajes-Eizagirre; Amit Lazarov; Xi Zhu; Ben J Harrison; Joaquim Radua; Yuval Neria; Miquel A Fullana
Journal:  Psychol Med       Date:  2019-07-01       Impact factor: 7.723

6.  Fear Extinction Retention: Is It What We Think It Is?

Authors:  Tina B Lonsdorf; Christian J Merz; Miquel A Fullana
Journal:  Biol Psychiatry       Date:  2019-02-19       Impact factor: 13.382

7.  Behavioral versus cognitive treatment of obsessive-compulsive disorder: an examination of outcome and mediators of change.

Authors:  Bunmi O Olatunji; David Rosenfield; Candyce D Tart; Jean Cottraux; Mark B Powers; Jasper A J Smits
Journal:  J Consult Clin Psychol       Date:  2013-02-18

Review 8.  Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).

Authors:  G M Soomro; D Altman; S Rajagopal; M Oakley-Browne
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

9.  Impaired P50 suppression in fear extinction in obsessive-compulsive disorder.

Authors:  Makoto Nanbu; Taichi Kurayama; Ken Nakazawa; Daisuke Matsuzawa; Zen Komiya; Tadashi Haraguchi; Hirohisa Ogura; Tasuku Hashimoto; Susumu Yoshida; Masaomi Iyo; Eiji Shimizu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-12-24       Impact factor: 5.067

10.  Emotion Regulation Therapy: A Mechanism-Targeted Treatment for Disorders of Distress.

Authors:  Megan E Renna; Jean M Quintero; David M Fresco; Douglas S Mennin
Journal:  Front Psychol       Date:  2017-02-06
View more
  4 in total

1.  Analysis of lateral orbitofrontal cortex activation on acquisition of fear extinction and neuronal activities in fear circuit.

Authors:  Cheng-Chia Shih; Yu-Hsuan Chang; Ruei-Jen Chiou; Chun-Hui Chang
Journal:  Brain Struct Funct       Date:  2022-08-02       Impact factor: 3.748

2.  A meta-analysis of conditioned fear generalization in anxiety-related disorders.

Authors:  Samuel E Cooper; Eva A M van Dis; Muriel A Hagenaars; Angelos-Miltiadis Krypotos; Charles B Nemeroff; Shmuel Lissek; Iris M Engelhard; Joseph E Dunsmoor
Journal:  Neuropsychopharmacology       Date:  2022-04-30       Impact factor: 8.294

3.  Threat reversal learning and avoidance habits in generalised anxiety disorder.

Authors:  Clark Roberts; Annemieke M Apergis-Schoute; Annette Bruhl; Magda Nowak; David S Baldwin; Barbara J Sahakian; Trevor W Robbins
Journal:  Transl Psychiatry       Date:  2022-05-31       Impact factor: 7.989

4.  Abnormal spontaneous neural activity in hippocampal-cortical system of patients with obsessive-compulsive disorder and its potential for diagnosis and prediction of early treatment response.

Authors:  Haohao Yan; Xiaoxiao Shan; Huabing Li; Feng Liu; Wenbin Guo
Journal:  Front Cell Neurosci       Date:  2022-07-15       Impact factor: 6.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.